Diehl Remedio De Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diehl Remedio De Souza has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Michael R. Nonnemacher
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, USA
2 shared publications - Ahmed Azad
Department of Microbiology and Immunology, Drexel University College of Medicine, 245 N 15 St, Philadelphia, PA, 19102, USA
1 shared publication Bhaswati Sen
Department of Microbiology and Immunology, Drexel University College of Medicine, 245 N 15 St, Philadelphia, PA, 19102, USA
1 shared publication- Brian Wigdahl
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, USA
1 shared publication - Jill M. Lawrence
Center for Genomic Sciences, Institute of Molecular Medicine and Infectious Disease; Drexel University
1 shared publication - Joshua Chang Mell
Department of Microbiology and Immunology, Drexel University College of Medicine
1 shared publication
Latest Publications
- Open Access
- 4 December 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 251
Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.
- 4 December 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 251
Open AccessInflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.
- 11 January 2022
- Published by Drexel University Libraries
Assessment of genes in defective integrated HIV-1 provirus within the PBMC compartment of individuals with neuroHIV
The integrated human immunodeficiency virus type 1 (HIV-1) provirus forms a stable but transcriptionally silent viral reservoir in the host. Studies have also shown that this viral reservoir contains both replication-competent and defective-proviral sequences. At least some defective proviruses may still be able to produce viral proteins which may contribute to chronic HIV-1 pathogenesis and disease. We have previously studied genetic variation associated with the expression of the viral accessory protein Tat in an attempt to link this variation to functional outcomes. Sequencing of the HIV-1 genome showed an approximate 40 percent failure rate in amplifying the tat gene region. This could be due to genetic variation at the site of the PCR primer complementarity, low HIV-1 target genome copies in the peripheral blood mononuclear cell (PBMC) population, or a lack of target due to defective provirus. We hypothesized that the reason for such variable results could be due to accumulation of replication incompetent defective proviruses. Given these observations, we used a near-full length (NFL) PCR amplification strategy to examine the full spectrum of integrated proviruses contained within the PBMC compartment of individuals in the absence or presence of neuroHIV. The HIV protein Tat has been linked to cause neuropathogenesis on its own. Tat is the only viral regulatory protein detectable in therapy-controlled individuals. Tat has also been shown to be made in latently infected cells. Given this, we hypothesized that the more the tat gene was present, the more likely it could be for the individual having neurocognitive impairment. Amplicon analyses were conducted utilizing a third-generation sequencing (TGS) platform, Nanopore's MinION. Initial results showed defective virus as the predominant species in most individuals. Further analysis showed a trend toward tat gene presence correlating to neurocognitive impairment.
- 11 January 2022
- Published by Drexel University Libraries
Assessment of genes in defective integrated HIV-1 provirus within the PBMC compartment of individuals with neuroHIV
The integrated human immunodeficiency virus type 1 (HIV-1) provirus forms a stable but transcriptionally silent viral reservoir in the host. Studies have also shown that this viral reservoir contains both replication-competent and defective-proviral sequences. At least some defective proviruses may still be able to produce viral proteins which may contribute to chronic HIV-1 pathogenesis and disease. We have previously studied genetic variation associated with the expression of the viral accessory protein Tat in an attempt to link this variation to functional outcomes. Sequencing of the HIV-1 genome showed an approximate 40 percent failure rate in amplifying the tat gene region. This could be due to genetic variation at the site of the PCR primer complementarity, low HIV-1 target genome copies in the peripheral blood mononuclear cell (PBMC) population, or a lack of target due to defective provirus. We hypothesized that the reason for such variable results could be due to accumulation of replication incompetent defective proviruses. Given these observations, we used a near-full length (NFL) PCR amplification strategy to examine the full spectrum of integrated proviruses contained within the PBMC compartment of individuals in the absence or presence of neuroHIV. The HIV protein Tat has been linked to cause neuropathogenesis on its own. Tat is the only viral regulatory protein detectable in therapy-controlled individuals. Tat has also been shown to be made in latently infected cells. Given this, we hypothesized that the more the tat gene was present, the more likely it could be for the individual having neurocognitive impairment. Amplicon analyses were conducted utilizing a third-generation sequencing (TGS) platform, Nanopore's MinION. Initial results showed defective virus as the predominant species in most individuals. Further analysis showed a trend toward tat gene presence correlating to neurocognitive impairment.